These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Drug disease interactions: role of inflammatory mediators in disease and variability in drug response. Kulmatycki KM; Jamali F J Pharm Pharm Sci; 2005 Dec; 8(3):602-25. PubMed ID: 16401407 [TBL] [Abstract][Full Text] [Related]
3. Pravastatin reverses the down-regulating effect of inflammation on beta-adrenergic receptors: a disease-drug interaction between inflammation, pravastatin, and propranolol. Clements JD; Jamali F Vascul Pharmacol; 2007 Jan; 46(1):52-9. PubMed ID: 16949884 [TBL] [Abstract][Full Text] [Related]
4. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937 [TBL] [Abstract][Full Text] [Related]
5. Drug disease interactions: role of inflammatory mediators in depression and variability in antidepressant drug response. Kulmatycki KM; Jamali F J Pharm Pharm Sci; 2006; 9(3):292-306. PubMed ID: 17207413 [TBL] [Abstract][Full Text] [Related]
7. Cytokines and heart failure. Paulus WJ Heart Fail Monit; 2000; 1(2):50-6. PubMed ID: 12634874 [TBL] [Abstract][Full Text] [Related]
8. Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. Sijben JW; Calder PC Proc Nutr Soc; 2007 May; 66(2):237-59. PubMed ID: 17466105 [TBL] [Abstract][Full Text] [Related]
9. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin. Goldstein SL; Leung JC; Silverstein DM Clin J Am Soc Nephrol; 2006 Sep; 1(5):979-86. PubMed ID: 17699316 [TBL] [Abstract][Full Text] [Related]
10. [Proinflammatory cytokines in cardiovascular diseases as potential therapeutic target]. Bielecka-Dabrowa A; Wierzbicka M; Goch JH Wiad Lek; 2007; 60(9-10):433-8. PubMed ID: 18350717 [TBL] [Abstract][Full Text] [Related]
11. Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma. Herbert C; Hettiaratchi A; Webb DC; Thomas PS; Foster PS; Kumar RK Clin Exp Allergy; 2008 May; 38(5):847-56. PubMed ID: 18307529 [TBL] [Abstract][Full Text] [Related]
12. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms. Loppnow H; Werdan K; Buerke M Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724 [TBL] [Abstract][Full Text] [Related]
13. [Cardiovascular comorbidity in rheumatic disease. Does sex play a role?]. Kung M; Störk S; Angermann CE Herz; 2005 Sep; 30(6):512-21. PubMed ID: 16170682 [TBL] [Abstract][Full Text] [Related]
14. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
15. Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma. Frampton MW; Utell MJ; Zareba W; Oberdörster G; Cox C; Huang LS; Morrow PE; Lee FE; Chalupa D; Frasier LM; Speers DM; Stewart J Res Rep Health Eff Inst; 2004 Dec; (126):1-47; discussion 49-63. PubMed ID: 15768531 [TBL] [Abstract][Full Text] [Related]
16. Cytokine toxicity to oligodendrocyte precursors is mediated by iron. Zhang X; Haaf M; Todorich B; Grosstephan E; Schieremberg H; Surguladze N; Connor JR Glia; 2005 Nov; 52(3):199-208. PubMed ID: 15968631 [TBL] [Abstract][Full Text] [Related]
17. Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. Reale M; Iarlori C; Gambi F; Feliciani C; Salone A; Toma L; DeLuca G; Salvatore M; Conti P; Gambi D J Neuroimmunol; 2004 Mar; 148(1-2):162-71. PubMed ID: 14975597 [TBL] [Abstract][Full Text] [Related]
18. Inflammatory mediators in the elderly. Krabbe KS; Pedersen M; Bruunsgaard H Exp Gerontol; 2004 May; 39(5):687-99. PubMed ID: 15130663 [TBL] [Abstract][Full Text] [Related]
19. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse. Vick MM; Adams AA; Murphy BA; Sessions DR; Horohov DW; Cook RF; Shelton BJ; Fitzgerald BP J Anim Sci; 2007 May; 85(5):1144-55. PubMed ID: 17264235 [TBL] [Abstract][Full Text] [Related]
20. Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in nonhuman immunodeficiency virus-infected subjects with no lymphadenopathy: the parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches. Prandota J Am J Ther; 2007; 14(1):63-105. PubMed ID: 17303977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]